The most frequently mutated genes at the time of AML transformation in our cohort were SRSF2, TET2, ASXL1, IDH2, RUNX1, NRAS, SETBP1, and DNMT3A. This evidence concerns the gene SRSF2 and acute myeloid leukemia.